Kiwa Bio-Tech Products Group Corporation
KWBT · OTC
12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Revenue | $40 | $31 | $17 | $10 |
| % Growth | 30.8% | 77.5% | 79.6% | – |
| Cost of Goods Sold | $31 | $22 | $12 | $8 |
| Gross Profit | $9 | $8 | $5 | $2 |
| % Margin | 23.3% | 26.9% | 31.4% | 20.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $4 | $5 | $3 | $1 |
| SG&A Expenses | $5 | $6 | $3 | $1 |
| Sales & Mktg Exp. | $0 | $1 | $0 | $0 |
| Other Operating Expenses | $2 | -$0 | $0 | $0 |
| Operating Expenses | $7 | $6 | $4 | $1 |
| Operating Income | -$1 | $3 | $2 | $1 |
| % Margin | -3% | 8.4% | 10.4% | 8.3% |
| Other Income/Exp. Net | -$4 | -$0 | $0 | $1 |
| Pre-Tax Income | -$5 | $2 | $2 | $1 |
| Tax Expense | $2 | $2 | $1 | $0 |
| Net Income | -$7 | $0 | $5 | $1 |
| % Margin | -16.6% | 1.1% | 30.7% | 10% |
| EPS | -0.29 | 0.021 | 0.51 | 0.17 |
| % Growth | -1,494.2% | -95.9% | 200% | – |
| EPS Diluted | -0.29 | 0.021 | 0.43 | 0.09 |
| Weighted Avg Shares Out | 23 | 17 | 10 | 5 |
| Weighted Avg Shares Out Dil | 23 | 17 | 13 | 11 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $4 | $1 | $1 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | $3 | $2 | $2 |
| % Margin | -2.5% | 8.5% | 12.9% | 16.7% |